Evidence map›Paper›PMID 24970154›Full record

ArticleBiomolecules2012

Molecular Insights into Poly(ADP-ribose) Recognition and Processing.

Roko Zaja, Andreja Mikoč, Eva Barkauskaite, Ivan Ahel

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 52 citations in OpenAlex.

  1. Prospects for PARG inhibitors in cancer therapy.Journal of molecular cell biology · 2025
    Review
  2. Article
  3. Review
  4. Review
  5. Rapid Detection and Signaling of DNA Damage by PARP-1.Trends in biochemical sciences · 2021
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Functions of PARylation in DNA Damage Repair Pathways.Genomics, proteomics & bioinformatics · 2016
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Roko ZajaCancer Research UK, Paterson Institute for Cancer Research, University of Manchester, Wilmslow Road, Manchester M20 4BX, UK. mikoc@irb.hr.
Andreja MikočRudjer Boskovic Institute, Bijenicka 54, Zagreb 10000, Croatia. mikoc@irb.hr.
Eva BarkauskaiteCancer Research UK, Paterson Institute for Cancer Research, University of Manchester, Wilmslow Road, Manchester M20 4BX, UK. EBarkauskaite@picr.man.ac.uk.
Ivan AhelCancer Research UK, Paterson Institute for Cancer Research, University of Manchester, Wilmslow Road, Manchester M20 4BX, UK. iahel@picr.man.ac.uk.
Rudjer Boskovic Institute · HRCancer Research UK Manchester Institute · GBUniversity of Manchester · GB

Funding

European Research Council 281739
6 · The paper itself

Abstract

Poly(ADP-ribosyl)ation is a post-translational protein modification involved in the regulation of important cellular functions including DNA repair, transcription, mitosis and apoptosis. The amount of poly(ADP-ribosyl)ation (PAR) in cells reflects the balance of synthesis, mediated by the PARP protein family, and degradation, which is catalyzed by a glycohydrolase, PARG. Many of the proteins mediating PAR metabolism possess specialised high affinity PAR-binding modules that allow the efficient sensing or processing of the PAR signal. The identification of four such PAR-binding modules and the characterization of a number of proteins utilising these elements during the last decade has provided important insights into how PAR regulates different cellular activities. The macrodomain represents a unique PAR-binding module which is, in some instances, known to possess enzymatic activity on ADP-ribose derivatives (in addition to PAR-binding). The most recently discovered example for this is the PARG protein, and several available PARG structures have provided an understanding into how the PARG macrodomain evolved into a major enzyme that maintains PAR homeostasis in living cells.

Identifiers

PMID24970154
PMCPMC4030884
OpenAlexW2029849395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.